Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
ResMed (RMD UN)
Watchlist
23
Analysis
Health Care
•
United States
ResMed Inc. develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing. The Company sells diagnostic and treatment devices in various countries through its subsidiaries and independent distributors.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
ResMed Inc
•
27 May 2026 06:01
ResMed (RMD AU) Vs. F&P Health (FPH AU): Earnings Jump Triggers Stat Arb Signal
8% target return in a potential pair trade after Fisher & Paykel Health’s earnings jump pushed the healthcare spread beyond a two-standard...
Gaudenz Schneider
Follow
167 Views
Share
bullish
•
ICICI Prudential Life Insurance
•
25 May 2026 04:30
Relative Value Opportunities in Asia-Pac, Pair Trade Roundup (25 May 2026)
​Discover 18 pair trade opportunities across four markets and seven sectors using statistical mean-reversion methodology for actionable insights.
Gaudenz Schneider
Follow
123 Views
Share
bullish
•
Cross Asset Strategy
•
20 Oct 2018 08:35
It’s Not Over Yet, but Lift the Bar on Defence
A Correction and Not the End of the Cycle. In our view, the equity market sell-off in the past few weeks is a correction and a return to more...
Shane Lee
606 Views
Share
bullish
•
S&P 500 INDEX
•
19 Sep 2018 20:19
U.S. Equity Strategy: Cyclicals Remain Leadership - Staples & Utilities Are Strengthening
Investors continue to prefer the stability of the U.S. relative to emerging markets. The recent declines recorded in emerging markets and their...
Vermilion Research
Follow
636 Views
Share
bullish
•
J Front Retailing
•
17 May 2026 06:04
Relative Value Opportunities in Asia-Pac, Pair Trade Roundup (18 May 2026)
​Discover 15 pair trade opportunities across four markets and seven sectors using statistical mean-reversion methodology for actionable insights.
Gaudenz Schneider
Follow
99 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x